The rHA 20% product, derived from yeast, is a highly purified alternative to human serum albumin, matching it structurally ...

Shilpa Medicare Ltd announces that the results of its Phase I clinical trials were accepted by Subject Expert Committee ...

Shilpa Medicare's Recombinant Human Albumin 20% (rHA) is derived from yeast and offers a highly purified, structurally and ...

Shilpa Medicare has informed that the subject expert committee (Haematology) (SEC) has accepted the results of its Phase I clinical trials for Recombinant Human Albumin (rHA) 20% and granted approval ...

In relation to the successful completion of Phase I clinical trials, Shilpa Medicare Ltd has announced that the Subject ...

Good evening, and welcome to Dyadic International Q3 2024 Conference Call. Currently, all participants are in a listen-only ...

The studies discovered that favorable nanoparticle-protein interactions can be predicted from machine learning models that ...

Machine learning and supercomputer simulations have been used to investigate how tiny gold nanoparticles bind to blood ...

Albumin human is derived from human plasma ... It increases blood plasma volume or serum albumin levels. Adult: IV- Acute hypovolemic shock- Initial: 25 g, adjust according to response.